Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.
On November 29, 19898, the Food and Drug Administration (FDA) issued recommendations to screen all whole blood donations in the United States for human T-lymphotropic virus type I (HTLV-1). This report summarizes results of the first 13 months of screening (December 1988 through December 1989) by the American Red Cross (ARC) and the Council of Community Blood Centers (CCBC).
D001782:Blood Donors; D006800:Deltaretrovirus Infections / Q000175:diagnosis; D005260:Female; D015490:HTLV-I Infections / Q000175:diagnosis* / Q000453:epidemiology; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D015367:Human T-lymphotropic virus 2 / Q000302:isolation & purification; D006801:Humans; D007118:Immunoassay; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000175:diagnosis / Q000453:epidemiology; D008297:Male; D014481:United States / Q000453:epidemiology